Disclosed are mixtures comprising sulfated xylan molecules having a molecular weight between 1000 and 6000 Da wherein the sulfur is present in at least 17 wt. % based on the weight of the sodium salt. The mixtures are useful in the treatment of non-infective inflammatory diseases such as osteoarthritis.